Biochemical properties of anti-inflammatory drugs. X. The inhibition of serotonin formation in vitro and inhibition of the esterase activity of alpha-chymyotrypsin.
D000311:Adrenal Glands / Q000201:enzymology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002262:Carboxy-Lyases / Q000378:metabolism*; D002417:Cattle; D055598:Chemical Phenomena; D002621:Chemistry; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D002918:Chymotrypsin / Q000378:metabolism*; D004950:Esterases / Q000378:metabolism; D005439:Flufenamic Acid / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008528:Mefenamic Acid / Q000494:pharmacology; D010085:Oxidative Phosphorylation; D010648:Phenylacetates / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D012459:Salicylates; D062367:ortho-Aminobenzoates; D012701:Serotonin; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D004950:Esterases; D002918:Chymotrypsin; D002262:Carboxy-Lyases; D010653:Phenylbutazone; D007213:Indomethacin